{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:10:21Z","timestamp":1787314221428,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Eye Institute grant NIH\/NEI","award":["5K08EY027464-02"],"award-info":[{"award-number":["5K08EY027464-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00345-020-03441-3","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T18:56:01Z","timestamp":1600282561000},"page":"2409-2415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Jad","family":"Chahoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nainesh","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S.","family":"Boris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othon","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Kimryn","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jonasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International VHL Surveillance Guidelines Consortium-Renal Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"issue":"7","key":"3441_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jama.1995.03520310062031","volume":"273","author":"WM Linehan","year":"1995","unstructured":"Linehan WM, Lerman MI, Zbar B (1995) Identification of the von Hippel\u2013Lindau (VHL) gene: its role in renal cancer. JAMA J Am Med Assoc 273(7):564\u2013570. https:\/\/doi.org\/10.1001\/jama.1995.03520310062031","journal-title":"JAMA J Am Med Assoc"},{"issue":"6","key":"3441_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HPH, Richard S (2011) von Hippel\u2013Lindau disease: a clinical and scientific review. Eur J Hum Genet 19(6):617\u2013623. https:\/\/doi.org\/10.1038\/ejhg.2010.175","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"3441_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","volume":"4","author":"N Varshney","year":"2017","unstructured":"Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS (2017) A review of von Hippel\u2013Lindau syndrome. J Kidney Cancer VHL 4(3):20. https:\/\/doi.org\/10.15586\/jkcvhl.2017.88","journal-title":"J Kidney Cancer VHL"},{"issue":"1","key":"3441_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER (2015) VHL, the story of a tumour suppressor gene. Nat Rev Cancer 15(1):55\u201364. https:\/\/doi.org\/10.1038\/nrc3844","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3441_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","volume":"54","author":"MLM Binderup","year":"2017","unstructured":"Binderup MLM, Jensen AM, Budtz-J\u00f8rgensen E, Bisgaard ML (2017) Survival and causes of death in patients with von Hippel\u2013Lindau disease. J Med Genet 54(1):11\u201318. https:\/\/doi.org\/10.1136\/jmedgenet-2016-104058","journal-title":"J Med Genet"},{"issue":"4","key":"3441_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.15586\/jkcvhl.2015.41","volume":"2","author":"K Ashouri","year":"2015","unstructured":"Ashouri K, Mohseni S, Tourtelot J, Sharma P, Spiess PE (2015) Implications of von Hippel\u2013Lindau syndrome and renal cell carcinoma. J Kidney Cancer VHL 2(4):163. https:\/\/doi.org\/10.15586\/jkcvhl.2015.41","journal-title":"J Kidney Cancer VHL"},{"issue":"12","key":"3441_CR7","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam SP, Erez A, Druker H et al (2017) von Hippel\u2013Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23(12):e68\u2013e75. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0547","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3441_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","volume":"194","author":"PL Choyke","year":"1995","unstructured":"Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1995) von Hippel\u2013Lindau disease: genetic, clinical, and imaging features. Radiology 194(3):629\u2013642. https:\/\/doi.org\/10.1148\/radiology.194.3.7862955","journal-title":"Radiology"},{"issue":"12","key":"3441_CR9","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","volume":"36","author":"ER Maher","year":"2018","unstructured":"Maher ER (2018) Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. World J Urol 36(12):1891\u20131898. https:\/\/doi.org\/10.1007\/s00345-018-2288-5","journal-title":"World J Urol"},{"key":"3441_CR10","doi-asserted-by":"crossref","unstructured":"Maher ER, Yates JR, Harries R et al (1990) Clinical features and natural history of von Hippel\u2013Lindau disease. Q J Med 77(283):1151\u20131163. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2274658. Accessed 27 Aug 2019","DOI":"10.1093\/qjmed\/77.2.1151"},{"key":"3441_CR11","doi-asserted-by":"crossref","unstructured":"Hes FJ, van der Luijt RB, Lips CJ (2001) Clinical management of von Hippel\u2013Lindau (VHL) disease. Neth J Med 59(5):225\u2013234. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11705642. Accessed 27 Aug 2019","DOI":"10.1016\/S0300-2977(01)00165-6"},{"issue":"18","key":"3441_CR12","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","volume":"34","author":"SM Nielsen","year":"2016","unstructured":"Nielsen SM, Rhodes L, Blanco I et al (2016) von Hippel\u2013Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol 34(18):2172\u20132181. https:\/\/doi.org\/10.1200\/JCO.2015.65.6140","journal-title":"J Clin Oncol"},{"issue":"9374","key":"3441_CR13","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M et al (2003) von Hippel\u2013Lindau disease. Lancet (London, England) 361(9374):2059\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet (London, England)"},{"key":"3441_CR14","unstructured":"HL family alliance: the VHL handbook: what you need to know about VHL: a reference handbook for people with von Hippel\u2013Lindau disease, their families, and support personnel. Boston, MA 2014 VHL Family Alliance. No Title"},{"issue":"4","key":"3441_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 64(4):401\u2013406. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.015","journal-title":"J Clin Epidemiol."},{"key":"3441_CR16","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume-title":"Lancet","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M et al (2003) von Hippel\u2013Lindau disease. Lancet, vol 361. Elsevier Limited, Amsterdam, pp 2059\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(03)13643-4"},{"key":"3441_CR17","unstructured":"Binderup ML, Bisgaard ML, Harbud V et al (2013) von Hippel\u2013Lindau disease (vHL): national clinical guideline for diagnosis and surveillance in Denmark. Dan Med J 60(12):B4763. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L370377660. Accessed 27 Aug 2019"},{"issue":"1","key":"3441_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/ERC-13-0308","volume":"21","author":"RC Kruizinga","year":"2014","unstructured":"Kruizinga RC, Sluiter WJ, de Vries EGE et al (2014) Calculating optimal surveillance for detection of von Hippel\u2013Lindau-related manifestations. Endocr Relat Cancer 21(1):63\u201371","journal-title":"Endocr Relat Cancer"},{"key":"3441_CR19","unstructured":"(2018) ACR manual on contrast media version 10.3, 2018, pp 81\u201387"},{"issue":"1","key":"3441_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.juro.2009.02.128","volume":"182","author":"RH Thompson","year":"2009","unstructured":"Thompson RH, Hill JR, Babayev Y et al (2009) Metastatic renal cell carcinoma risk according to tumor size. J Urol 182(1):41\u201345. https:\/\/doi.org\/10.1016\/j.juro.2009.02.128","journal-title":"J Urol"},{"issue":"4","key":"3441_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/cncr.26369","volume":"118","author":"MC Smaldone","year":"2012","unstructured":"Smaldone MC, Kutikov A, Egleston BL et al (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118(4):997\u20131006. https:\/\/doi.org\/10.1002\/cncr.26369","journal-title":"Cancer"},{"issue":"2","key":"3441_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0022-5347(05)00148-5","volume":"175","author":"SN Chawla","year":"2006","unstructured":"Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DYT, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175(2):425\u2013431. https:\/\/doi.org\/10.1016\/S0022-5347(05)00148-5","journal-title":"J Urol"},{"issue":"4","key":"3441_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.juro.2007.11.047","volume":"179","author":"DA Kunkle","year":"2008","unstructured":"Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma\u2014a meta-analysis and review. J Urol 179(4):1227\u20131234. https:\/\/doi.org\/10.1016\/j.juro.2007.11.047","journal-title":"J Urol"},{"issue":"1","key":"3441_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.eururo.2011.03.030","volume":"60","author":"MAS Jewett","year":"2011","unstructured":"Jewett MAS, Mattar K, Basiuk J et al (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60(1):39\u201344. https:\/\/doi.org\/10.1016\/j.eururo.2011.03.030","journal-title":"Eur Urol"},{"issue":"6","key":"3441_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4111\/icu.2017.58.6.429","volume":"58","author":"SW Park","year":"2017","unstructured":"Park SW, Lee SS, Lee DH, Nam JK, Chung MK (2017) Growth kinetics of small renal mass: initial analysis of active surveillance registry. Investig Clin Urol 58(6):429\u2013433. https:\/\/doi.org\/10.4111\/icu.2017.58.6.429","journal-title":"Investig Clin Urol"},{"issue":"5","key":"3441_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.eururo.2011.02.023","volume":"59","author":"RJ Mason","year":"2011","unstructured":"Mason RJ, Abdolell M, Trottier G et al (2011) Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol 59(5):863\u2013867. https:\/\/doi.org\/10.1016\/j.eururo.2011.02.023","journal-title":"Eur Urol"},{"issue":"3","key":"3441_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","volume":"68","author":"PM Pierorazio","year":"2015","unstructured":"Pierorazio PM, Johnson MH, Ball MW et al (2015) Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM Registry. Eur Urol 68(3):408\u2013415. https:\/\/doi.org\/10.1016\/j.eururo.2015.02.001","journal-title":"Eur Urol"},{"issue":"1","key":"3441_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000333348","volume":"88","author":"CA Jilg","year":"2012","unstructured":"Jilg CA, Neumann HP, Gl\u00e4sker S et al (2012) Growth kinetics in von Hippel\u2013Lindau-associated renal cell carcinoma. Urol Int 88(1):71\u201378. https:\/\/doi.org\/10.1159\/000333348","journal-title":"Urol Int"},{"issue":"1","key":"3441_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13023-019-1206-2","volume":"14","author":"P Schuhmacher","year":"2019","unstructured":"Schuhmacher P, Kim E, Hahn F et al (2019) Growth characteristics and therapeutic decision markers in von Hippel\u2013Lindau disease patients with renal cell carcinoma. Orphanet J Rare Dis 14(1):235. https:\/\/doi.org\/10.1186\/s13023-019-1206-2","journal-title":"Orphanet J Rare Dis"},{"issue":"13","key":"3441_CR30","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/cncr.24338","volume":"115","author":"PL Crispen","year":"2009","unstructured":"Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG (2009) Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 115(13):2844\u20132852. https:\/\/doi.org\/10.1002\/cncr.24338","journal-title":"Cancer"},{"issue":"7","key":"3441_CR31","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s00330-015-3591-9","volume":"25","author":"F Pomerri","year":"2015","unstructured":"Pomerri F, Opocher G, Bosco CD, Muzzio PC, Gennaro G (2015) Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel\u2013Lindau disease. Eur Radiol 25(7):2025\u20132032. https:\/\/doi.org\/10.1007\/s00330-015-3591-9","journal-title":"Eur Radiol"},{"issue":"2","key":"3441_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10689-011-9503-5","volume":"11","author":"J Zhang","year":"2012","unstructured":"Zhang J, Pan JH, Dong BJ, Xue W, Liu DM, Huang YR (2012) Active surveillance of renal masses in von Hippel\u2013Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer 11(2):209\u2013214. https:\/\/doi.org\/10.1007\/s10689-011-9503-5","journal-title":"Fam Cancer"},{"issue":"3","key":"3441_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.eururo.2012.05.009","volume":"62","author":"A Volpe","year":"2012","unstructured":"Volpe A, Finelli A, Gill IS et al (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62(3):491\u2013504. https:\/\/doi.org\/10.1016\/j.eururo.2012.05.009","journal-title":"Eur Urol"},{"issue":"1\u20132","key":"3441_CR34","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.5489\/cuaj.3417","volume":"10","author":"R Burruni","year":"2016","unstructured":"Burruni R, Lhermitte B, Cerantola Y et al (2016) The role of renal biopsy in small renal masses. Can Urol Assoc J 10(1\u20132):E28\u2013E33. https:\/\/doi.org\/10.5489\/cuaj.3417","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"3441_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.eururo.2015.07.072","volume":"69","author":"L Marconi","year":"2016","unstructured":"Marconi L, Dabestani S, Lam TB et al (2016) Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 69(4):660\u2013673. https:\/\/doi.org\/10.1016\/j.eururo.2015.07.072","journal-title":"Eur Urol"},{"issue":"4","key":"3441_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1897-4287-3-4-171","volume":"3","author":"FJ Hes","year":"2005","unstructured":"Hes FJ, H\u00f6ppener JW, Luijt RB, Lips CJ (2005) Von hippel-lindau disease. Hered Cancer Clin Pract 3(4):171\u2013178. https:\/\/doi.org\/10.1186\/1897-4287-3-4-171","journal-title":"Hered Cancer Clin Pract"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03441-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T19:48:02Z","timestamp":1631735282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03441-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3441"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03441-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"18 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kimryn Rathmell receives clinical research funding from Peloton. All other authors have no relevant conflict to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}